AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation
Open Access
- 6 September 2010
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 29 (44) , 5873-5882
Abstract
Activator protein one (AP1) (jun/fos) factors comprise a family of transcriptional regulators (c-jun, junB, junD, c-fos, FosB, Fra-1 and Fra-2) that are key controllers of epidermal keratinocyte survival and differentiation, and are important drivers of cancer development. Understanding the role of these factors in epidermis is complicated by the fact that each member is expressed in defined cell layers during epidermal differentiation, and because AP1 factors regulate competing processes (that is, proliferation, apoptosis and differentiation). We have proposed that AP1 factors function differently in basal versus suprabasal epidermis. To test this, we inactivated suprabasal AP1 factor function in mouse epidermis by targeted expression of dominant-negative c-jun (TAM67), which inactivates function of all AP1 factors. This produces increased basal keratinocyte proliferation, delayed differentiation and extensive hyperkeratosis. These findings contrast with previous studies showing that basal layer AP1 factor inactivation does not perturb resting epidermis. It is interesting that in spite of extensive keratinocyte hyperproliferation, susceptibility to carcinogen-dependent tumor induction is markedly attenuated. These novel observations strongly suggest that AP1 factors have distinct roles in the basal versus suprabasal epidermis, confirm that AP1 factor function is required for normal terminal differentiation, and suggest that AP1 factors have a different role in normal epidermis versus cancer progression.Keywords
This publication has 70 references indexed in Scilit:
- Synergistic Activation of Human Involucrin Gene Expression by Fra-1 and p300—Evidence for the Presence of a Multiprotein ComplexJournal of Investigative Dermatology, 2008
- Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytesMolecular Carcinogenesis, 2005
- Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsNature, 2005
- Epidermal growth factor (EGF)-mediated DNA-binding activity of AP-1 is attenuated in senescent human epidermal keratinocytesExperimental Dermatology, 2005
- A Regulatory Role for p38δ MAPK in Keratinocyte DifferentiationJournal of Biological Chemistry, 2003
- p38 Mitogen-Activated Protein Kinases on the Body Surface – A Function for p38δJournal of Investigative Dermatology, 2003
- Novel Protein Kinase C Isoforms Regulate Human Keratinocyte Differentiation by Activating a p38δ Mitogen-activated Protein Kinase Cascade That Targets CCAAT/Enhancer-binding Protein αJournal of Biological Chemistry, 2002
- The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiationOncogene, 2002
- AP-1 in cell proliferation and survivalOncogene, 2001
- Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotypeDifferentiation, 1993